Loading clinical trials...
Loading clinical trials...
A Phase 3, Open-Label Study of the Safety of HPN-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)
Conditions
Interventions
HPN-100
Locations
22
United States
Long Beach Memorial
Long Beach, California, United States
UCLA
Los Angeles, California, United States
Stanford University
Stanford, California, United States
Children's Hospital Colorado
Aurora, Colorado, United States
Yale School of Medicine
New Haven, Connecticut, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
Start Date
November 1, 2009
Primary Completion Date
September 1, 2011
Completion Date
November 1, 2011
Last Updated
July 10, 2024
NCT06805695
NCT06953505
NCT01257737
NCT00947544
NCT00992459
NCT03064048
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions